🔗 Share this article

This year's Nobel Prize in medical science has been granted for revolutionary findings that illuminate how the immune system targets dangerous infections while sparing the healthy tissues.

A trio of renowned scientists—Japan's Shimon Sakaguchi and US scientists Mary Brunkow and Dr. Ramsdell—share this accolade.

Their research identified unique "security guards" within the defense system that eliminate rogue immune cells that could attacking the body.

These discoveries are now enabling innovative treatments for immune disorders and malignancies.

The laureates will share a prize fund worth 11m SEK.

Crucial Findings

"Their research has been essential for understanding how the immune system functions and the reason we don't all develop severe self-attack conditions," stated the head of the award panel.

This trio's studies explain a fundamental mystery: How does the defense system protect us from numerous invaders while leaving our healthy cells unharmed?

The body's protection system employs white blood cells that scan for indicators of infection, including viruses and bacteria it has never encountered.

Such defenders employ detectors—called receptors—that are generated by chance in a vast number of variations.

That provides the immune system the capacity to combat a broad range of invaders, but the randomness of the process inevitably produces immune cells that may target the host.

Protectors of the Body

Scientists previously knew that a portion of these harmful defense cells were destroyed in the thymus—where immune cells develop.

The latest Nobel Prize honors the identification of T-reg cells—described as the immune system's "peacekeepers"—which travel through the body to neutralize any immune cells that attack the healthy cells.

We know that this mechanism fails in self-attack conditions such as type-1 diabetes, MS, and RA.

A Nobel panel added, "The discoveries have laid the foundation for a new field of research and accelerated the development of innovative treatments, for example for cancer and immune disorders."

In malignancies, regulatory T-cells prevent the body from fighting the growth, so studies are focused on lowering their quantity.

For self-attack disorders, experiments are exploring boosting T-reg cells so the body is no longer being harmed. A similar method could also be useful in minimizing the chances of transplanted organ failure.

Innovative Experiments

Professor Sakaguchi, from Osaka University, conducted experiments on mice that had their thymus removed, leading to self-attack conditions.

He showed that injecting immune cells from other mice could stop the illness—implying there was a system for blocking defenders from harming the body.

Dr. Brunkow, from the a research center in a US city, and Fred Ramsdell, currently at a biotech firm in a California city, were investigating an inherited immune disorder in rodents and humans that resulted in the identification of a gene critical for how T-regs operate.

"The pioneering work has revealed how the body's defenses is kept in check by regulatory T cells, stopping it from accidentally attacking the body's own tissues," said a prominent biological science specialist.

"This research is a striking illustration of how basic physiological study can have broad consequences for human health."